Ge, Shili <br/><br/>
Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab.  [electronic resource] 

 -  Transplant immunology  Apr 2011 
 - 142-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-5492 
<br/><br/><label>Standard No.: </label>10.1016/j.trim.2010.11.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Monoclonal, Murine-Derived--immunology<br/>Antibodies, Neoplasm--immunology<br/>B-Lymphocytes--metabolism<br/>Cytomegalovirus Infections--drug therapy<br/>Daclizumab<br/>Desensitization, Immunologic--adverse effects<br/>Female<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunoglobulin G--immunology<br/>Immunoglobulins--blood<br/>Immunoglobulins, Intravenous--immunology<br/>Kidney Transplantation<br/>Male<br/>Monitoring, Immunologic<br/>Rituximab<br/>T-Lymphocytes--metabolism